Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1118277.RACYQtkTWmJwBVfwfwrR1sJ19e6n97U6_tonY4gu_wbD0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1118277.RACYQtkTWmJwBVfwfwrR1sJ19e6n97U6_tonY4gu_wbD0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1118277.RACYQtkTWmJwBVfwfwrR1sJ19e6n97U6_tonY4gu_wbD0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1118277.RACYQtkTWmJwBVfwfwrR1sJ19e6n97U6_tonY4gu_wbD0130_provenance.
- NP1118277.RACYQtkTWmJwBVfwfwrR1sJ19e6n97U6_tonY4gu_wbD0130_assertion description "[The efficacy of the ACE (angiotensin-converting enzyme) inhibitor perindopril in coronary artery disease [EUROPA (European trial on reduction of cardiac events with perindopril in stable coronary artery disease) study] is associated with the rs12050217 A/G single nucleotide polymorphism in the B1 receptor (bradykinin type 1 receptor) gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1118277.RACYQtkTWmJwBVfwfwrR1sJ19e6n97U6_tonY4gu_wbD0130_provenance.
- NP1118277.RACYQtkTWmJwBVfwfwrR1sJ19e6n97U6_tonY4gu_wbD0130_assertion evidence source_evidence_literature NP1118277.RACYQtkTWmJwBVfwfwrR1sJ19e6n97U6_tonY4gu_wbD0130_provenance.
- NP1118277.RACYQtkTWmJwBVfwfwrR1sJ19e6n97U6_tonY4gu_wbD0130_assertion SIO_000772 24117346 NP1118277.RACYQtkTWmJwBVfwfwrR1sJ19e6n97U6_tonY4gu_wbD0130_provenance.
- NP1118277.RACYQtkTWmJwBVfwfwrR1sJ19e6n97U6_tonY4gu_wbD0130_assertion wasDerivedFrom befree-2016 NP1118277.RACYQtkTWmJwBVfwfwrR1sJ19e6n97U6_tonY4gu_wbD0130_provenance.
- NP1118277.RACYQtkTWmJwBVfwfwrR1sJ19e6n97U6_tonY4gu_wbD0130_assertion wasGeneratedBy ECO_0000203 NP1118277.RACYQtkTWmJwBVfwfwrR1sJ19e6n97U6_tonY4gu_wbD0130_provenance.
- befree-2016 importedOn "2016-02-19" NP1118277.RACYQtkTWmJwBVfwfwrR1sJ19e6n97U6_tonY4gu_wbD0130_provenance.